Detalles de la búsqueda
1.
Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial.
Haematologica
; 108(11): 3001-3010, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37259567
2.
Optimizing anti-T-lymphocyte globulin dosing to improve long-term outcome after unrelated hematopoietic cell transplantation for hematologic malignancies.
Am J Transplant
; 20(3): 677-688, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31597002
3.
High-dose melphalan-based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or refractory acute myeloid leukaemia.
Br J Haematol
; 180(6): 840-853, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29468631
4.
Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease.
Dig Dis Sci
; 61(7): 2019-26, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26995779
5.
KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3/CD19-depleted grafts.
Ann Hematol
; 93(9): 1579-86, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24771045
6.
Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients.
Blood
; 118(5): 1402-12, 2011 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-21540462
7.
Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.
Lancet Oncol
; 13(10): 1035-44, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22959335
8.
Allogeneic hematopoietic cell transplantation in patients age 60-70 years with de novo high-risk myelodysplastic syndrome or secondary acute myelogenous leukemia: comparison with patients lacking donors who received azacitidine.
Biol Blood Marrow Transplant
; 18(9): 1415-21, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22579634
9.
Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation.
N Engl J Med
; 371(9): 880-2, 2014 Aug 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-25162903
10.
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study.
Blood
; 116(10): 1795-802, 2010 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-20530284
11.
Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis.
Haematologica
; 97(10): 1574-81, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22491742
12.
Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial.
Haematologica
; 96(9): 1344-50, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21659356
13.
CD34+ highly enriched allogeneic stem cell transplantation in a patient with mixed phenotype acute leukemia and Fusarium solani sepsis.
Ann Hematol
; 95(1): 155-156, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26382275
14.
Retrospective evaluation of caspofungin therapy in invasive aspergillosis (RECAM-IA).
Mycoses
; 54(4): e148-53, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20202110
15.
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.
Lancet Haematol
; 7(1): e28-e39, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31606445
16.
Successful treatment of EBV PTLD with CNS lymphomas with the monoclonal anti-CD20 antibody rituximab.
Onkologie
; 31(12): 691-3, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19060508
17.
Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR.
J Clin Virol
; 99-100: 61-66, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29331844
18.
Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trial.
Lancet Haematol
; 5(4): e161-e169, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29550384
19.
No influence of gene polymorphism of LCT (C13910T) on transplantation outcomes in acute myeloid leukemia patients who received transplantations from HLA-identical sibling donors.
Blood
; 115(17): 3644-5; author reply 3645-6, 2010 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-20430969
20.
T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors.
Haematologica
; 92(4): 558-61, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17488669